Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannabis Growth Opportunity Corp (CGOC) was a Canadian investment corporation focused on the global cannabis industry. The company provided investors with a diversified portfolio of equity and debt instruments in both public and private cannabis-related businesses. Its investment mandate covered various sub-sectors, including cultivation, processing, retail, and cannabinoid-based research and development. CGOC aimed to achieve long-term capital appreciation by identifying high-growth opportunities and undervalued assets within the legal cannabis landscape. The company was publicly traded on the Canadian Securities Exchange under the ticker symbol CGOC. In July 2021, CGOC was acquired by Core One Labs Inc., a life sciences company focused on psychedelic medicines and delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannabis Growth Opportunity Corp.